« Return to News | Drug Sponsors

Eisai expands into Brazil

Friday, April 8, 2011 10:24 AM

Eisai, based in Japan, is moving into Latin America and is opening a subsidiary in Brazil, according to Pharma Times.

Eisai Brazil will be based in Sao Paulo, the country’s largest city, and will first establish "an initial infrastructure to support its operations debut" into that market. The company will focus on neurology, oncology and critical care.

Hajime Shimizu, president of new markets and the Association of Southeast Asian Nations (ASEAN) for Eisai, said the establishment of the unit "marks our entry into Latin America.” He added that the expansion "will enable us to introduce many of Eisai’s first-in-class products to people living in Brazil."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.